Australia markets closed

Algernon Pharmaceuticals Inc. (AGNPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1015-0.0039 (-3.67%)
At close: 11:02AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Cash flows from operating activities
Net income
-5,179
-6,781
-6,054
-7,734
-8,538
Depreciation & amortisation
41.241
50.398
34.936
0
0
Stock-based compensation
489.551
1,257
530.835
827.402
3,179
Change in working capital
1,439
1,266
2,584
-597.874
-1,069
Accounts receivable
58.395
567.802
1,614
-1,151
-
Other working capital
-1,653
-2,613
-3,057
-7,947
-6,710
Other non-cash items
-
40
-
-305.117
-
Net cash provided by operating activities
-1,597
-2,553
-2,913
-7,823
-6,610
Cash flows from investing activities
Investments in property, plant and equipment
-55.714
-59.5
-144.608
-124.448
-99.741
Net cash used for investing activities
-55.714
-59.5
-144.608
-124.448
-99.741
Cash flows from financing activities
Common stock issued
1,487
1,226
2,055
2,694
9,259
Other financing activities
-
-
-
-311.67
-
Net cash used provided by (used for) financing activities
1,509
1,329
2,055
4,245
12,620
Net change in cash
-144.309
-1,283
-1,003
-3,710
5,914
Cash at beginning of period
220.585
1,409
2,411
6,121
207.812
Cash at end of period
76.672
125.085
1,409
2,411
6,121
Free cash flow
Operating cash flow
-1,597
-2,553
-2,913
-7,823
-6,610
Capital expenditure
-55.714
-59.5
-144.608
-124.448
-99.741
Free cash flow
-1,653
-2,613
-3,057
-7,947
-6,710